Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases
Lina N. Zaripova, Angela Midgley, Stephen E. Christmas, Michael William Beresford, Clare E. Pain, Eileen M Baildam, Rachel A. Oldershaw
International Journal of Molecular Sciences · 2023 · ▲ 100 citations
Abstract
Mesenchymal stem cells (MSCs) modulate immune responses and maintain self-tolerance. Their trophic activities and regenerative properties make them potential immunosuppressants for treating autoimmune and autoinflammatory diseases. MSCs are drawn to sites of injury and inflammation where they can both reduce inflammation and contribute to tissue regeneration. An increased understanding of the role of MSCs in the development and progression of autoimmune disorders has revealed that MSCs are passive targets in the inflammatory process, becoming impaired by it and exhibiting loss of immunomodulatory activity. MSCs have been considered as potential novel cell therapies for severe autoimmune and autoinflammatory diseases, which at present have only disease modifying rather than curative treatment options. MSCs are emerging as potential therapies for severe autoimmune and autoinflammatory diseases. Clinical application of MSCs in rare cases of severe disease in which other existing treatment modalities have failed, have demonstrated potential use in treating multiple diseases, including rheumatoid arthritis, systemic lupus erythematosus, myocardial infarction, liver cirrhosis, spinal cord injury, multiple sclerosis, and COVID-19 pneumonia. This review explores the biological mechanisms behind the role of MSCs in autoimmune and autoinflammatory diseases. It also covers their immunomodulatory capabilities, potential therapeutic applications, and the challenges and risks associated with MSC therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms242216040
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Zaripova, L.N., Midgley, A., Christmas, S.E., Beresford, M.W., Pain, C.E., Baildam, E.M., & Oldershaw, R.A. (2023). Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms242216040
Vancouver
Zaripova LN, Midgley A, Christmas SE, Beresford MW, Pain CE, Baildam EM, et al. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216040.
BibTeX
@article{lina2023Mesenc,
title = {Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases},
author = {Lina N. Zaripova and Angela Midgley and Stephen E. Christmas and Michael William Beresford and Clare E. Pain and Eileen M Baildam and Rachel A. Oldershaw},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216040},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Arthritis Research & Therapy 2015
Open access · OA
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Stem Cells Translational Medicine 2011
Open access · OA
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Korean journal of family medicine 2025
Open access · OA
Systemic aging delay and anti-aging therapy using allogeneic stem cells.
World Journal of Stem Cells 2010
Open access · CC-BY
Mesenchymal stem cells: Molecular characteristics and clinical applications
Cellular and Molecular Immunology 2023
Open access · CC-BY
Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications
International Journal of Molecular Sciences 2021
Open access · CC-BY